These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27578275)

  • 41. Parallel Metabolomic Profiling of Cerebrospinal Fluid and Serum for Identifying Biomarkers of Injury Severity after Acute Human Spinal Cord Injury.
    Wu Y; Streijger F; Wang Y; Lin G; Christie S; Mac-Thiong JM; Parent S; Bailey CS; Paquette S; Boyd MC; Ailon T; Street J; Fisher CG; Dvorak MF; Kwon BK; Li L
    Sci Rep; 2016 Dec; 6():38718. PubMed ID: 27966539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolomic Coverage of Chemical-Group-Submetabolome Analysis: Group Classification and Four-Channel Chemical Isotope Labeling LC-MS.
    Zhao S; Li H; Han W; Chan W; Li L
    Anal Chem; 2019 Sep; 91(18):12108-12115. PubMed ID: 31441644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies.
    Brown MV; McDunn JE; Gunst PR; Smith EM; Milburn MV; Troyer DA; Lawton KA
    Genome Med; 2012 Apr; 4(4):33. PubMed ID: 22546470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dansylation metabolite assay: a simple and rapid method for sample amount normalization in metabolomics.
    Wu Y; Li L
    Anal Chem; 2014 Oct; 86(19):9428-33. PubMed ID: 25215550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
    Khodayari Moez E; Pyne S; Dinu I
    Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
    Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
    Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlling Preanalytical Process in High-Coverage Quantitative Metabolomics: Spot-Sample Collection for Mouse Urine and Fecal Metabolome Profiling.
    Chen D; Yu J; Zhang Z; Su X; Li L; Li L
    Anal Chem; 2019 Apr; 91(8):4958-4963. PubMed ID: 30900868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal Fluid Metabolomics After Natural Product Treatment in an Experimental Model of Cerebral Ischemia.
    Huan T; Xian JW; Leung WN; Li L; Chan CW
    OMICS; 2016 Nov; 20(11):670-680. PubMed ID: 27732148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.
    Shuster JR; Lance RS; Troyer DA
    BMC Clin Pathol; 2011 Dec; 11():14. PubMed ID: 22188997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of total concentration of chemically labeled metabolites as a means of metabolome sample normalization and sample loading optimization in mass spectrometry-based metabolomics.
    Wu Y; Li L
    Anal Chem; 2012 Dec; 84(24):10723-31. PubMed ID: 23190334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
    Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
    Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ion-pairing reversed-phase liquid chromatography fractionation in combination with isotope labeling reversed-phase liquid chromatography-mass spectrometry for comprehensive metabolome profiling.
    Guo K; Peng J; Zhou R; Li L
    J Chromatogr A; 2011 Jun; 1218(23):3689-94. PubMed ID: 21543078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics.
    Zang X; Jones CM; Long TQ; Monge ME; Zhou M; Walker LD; Mezencev R; Gray A; McDonald JF; Fernández FM
    J Proteome Res; 2014 Jul; 13(7):3444-54. PubMed ID: 24922590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
    Lima AR; Araújo AM; Pinto J; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes de Pinho P
    Sci Rep; 2018 Apr; 8(1):5539. PubMed ID: 29615722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies.
    Morse N; Jamaspishvili T; Simon D; Patel PG; Ren KYM; Wang J; Oleschuk R; Kaufmann M; Gooding RJ; Berman DM
    Lab Invest; 2019 Oct; 99(10):1561-1571. PubMed ID: 31160688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
    Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
    Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.